Ozempic now indicated to prevent CKD progression

Ozempic is the first medicine in Australia approved to slow kidney disease progression in patients with both type 2 diabetes and CKD.

PSA to accredit CPD against new standards from January

At the end of the year, the APC will retire its Accreditation Standards for Continuing Professional Development Activities.

Are pharmacists the next cosmetic injectors?

Some pharmacists have recently pondered the possibility of administering cosmetic injectables such as Botox and dermal fillers, reaching out to PSA’s Pharmacist to Pharmacist...

Queen’s Birthday Honours for pharmacists

Three pharmacists were recognised in this year’s Queen’s Birthday Honours List, highlighting the varied and important roles pharmacists play in their communities.

How pharmacists can support patients through the PrEP shortage

The Therapeutic Goods Administration has announced shortages on several brands of HIV PrEP medicines, concerning healthcare professionals.

Pharmacy prescribing trial expands to include skin conditions

With New South Wales recently expanding its pharmacy prescribing trial to include skin conditions, could other jurisdictions soon follow?